STOCK TITAN
  1. Home
  2. Sec-filings
  3. LASE
  4. [8-K] Laser Photonics Corp Reports Material Event

Laser Photonics (NASDAQ: LASE) CEO starts 3‑month health leave, EVP Ann Tewari named interim leader

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Laser Photonics Corporation announced a management change as President and CEO Wayne Tupuola informed the Board and employees that he will take a three-month leave of absence for health reasons. The Board appointed Ann Tewari, currently Executive Vice President of Global Operations and Strategy, as Interim President to lead the company during his absence.

Positive

  • None.

Negative

  • Health-related CEO leave: President and CEO Wayne Tupuola will be on a three-month health-related leave of absence, creating near-term uncertainty around strategic leadership and external stakeholder relationships.

Insights

Temporary CEO health-related leave introduces leadership risk, partly mitigated by an internal interim appointment.

Laser Photonics disclosed that President and CEO Wayne Tupuola will take a three-month health-related leave of absence. Such leaves can raise questions about continuity of strategic initiatives and key customer and investor relationships.

The Board named existing Executive Vice President of Global Operations and Strategy, Ann Tewari, as Interim President. Selecting a senior internal executive helps preserve operational familiarity and existing plans. However, the filing does not detail broader succession planning or any changes to strategy during this interim period.

Investors may focus on how smoothly daily operations and strategic projects proceed under Tewari’s interim leadership, and on future disclosures regarding Tupuola’s return and any potential longer-term adjustments to the leadership structure.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
CEO leave duration three-month leave of absence Health-related leave for President and CEO Wayne Tupuola
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Item 5.02 regulatory
"Item 5.02 Departure of Directors or Certain Officers"
Interim President financial
"appointed Ann Tewari ... as Interim President of the Company"
Executive Vice President of Global Operations and Strategy financial
"currently the Company’s Executive Vice President of Global Operations and Strategy"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →
false 0001807887 0001807887 2026-06-16 2026-06-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 16, 2026

 

Laser Photonics Corporation

(Exact name of registrant as specified in its charter)

 

Delaware   001-41515   84-3628771
(State of other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

250 Technology Park    
Lake Mary, FL   32746
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (407) 804-1000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of exchange on which registered
Common Stock, par value $0.001 per share   LASE   The NASDAQ Stock Market LLC

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On June 16, 2026, Wayne Tupuola, President and CEO of the Company, informed the Company’s Board of Directors (the “Board”) and the Company’s employees that he would be taking a three-month leave of absence for health reasons. The Board appointed Ann Tewari, currently the Company’s Executive Vice President of Global Operations and Strategy, as Interim President of the Company.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibits

 

  104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

-2-

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date:  June 23, 2026 Laser Photonics Corporation
       
    By: /s/ Ann Tewari
      Ann Tewari
      Interim President

 

-3-

Source: View Original Filing on SEC EDGAR

FAQ

What leadership change did Laser Photonics Corporation (LASE) disclose?

Laser Photonics announced that President and CEO Wayne Tupuola will take a three-month health-related leave of absence. The Board appointed executive Ann Tewari as Interim President to oversee the company’s operations during this period and maintain leadership continuity.

Who is serving as interim leader at Laser Photonics Corporation (LASE)?

The company appointed Ann Tewari, its Executive Vice President of Global Operations and Strategy, as Interim President. Her appointment provides continuity, as she is already a senior leader familiar with Laser Photonics’ operations and strategic initiatives.

How long will Laser Photonics’ CEO be on leave?

President and CEO Wayne Tupuola informed the Board and employees that he will take a three-month leave of absence for health reasons. The filing does not provide additional details about his condition or any changes to this expected timeframe.

Does the Laser Photonics (LASE) filing mention a change in strategy?

The disclosure focuses on Wayne Tupuola’s three-month leave and Ann Tewari’s appointment as Interim President. It does not describe any changes in Laser Photonics’ business strategy, financial guidance, or operational plans associated with this temporary leadership transition.

What SEC item does the Laser Photonics (LASE) leadership update fall under?

The leadership change is reported under Item 5.02, which covers departures or appointments of directors and certain officers, and compensatory arrangements. This signals that the temporary CEO leave and interim appointment are considered material corporate governance developments.

Filing Exhibits & Attachments

3 documents

Other Documents